DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 148 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2015. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $605,000 | -62.2% | 153,252 | +0.3% | 0.00% | -50.0% |
Q3 2016 | $1,602,000 | -25.6% | 152,732 | +3.4% | 0.00% | -33.3% |
Q2 2016 | $2,153,000 | -14.9% | 147,646 | +12.3% | 0.00% | 0.0% |
Q1 2016 | $2,529,000 | -18.4% | 131,426 | +2.5% | 0.00% | -25.0% |
Q4 2015 | $3,098,000 | -0.7% | 128,219 | +0.8% | 0.00% | 0.0% |
Q3 2015 | $3,121,000 | +27.9% | 127,170 | +22.1% | 0.00% | +33.3% |
Q2 2015 | $2,441,000 | +14.1% | 104,195 | +9.3% | 0.00% | 0.0% |
Q1 2015 | $2,139,000 | +45.8% | 95,366 | +9.6% | 0.00% | +50.0% |
Q4 2014 | $1,467,000 | – | 87,011 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |